20Feb 2021

RISPERIDONE INDUCED LEUCOPENIA AND NEUTROPENIA: A CASE REPORT AND BRIEF REVIEW OF LITERATURE

  • Department of Psychiatry, IBN NAFIS Hospital, Mohammed VI University Hospita Marrakech, Morocco.
  • Abstract
  • Cite This Article as
  • Corresponding Author

Hematological abnormalities are frequently encountered during treatment with antipsychotic drugs. Most of these are mild and of no clinical significance, but in a small minority of patients, hazardous, potentially life-threatening hematological effects, including leucopenia, neutropenia, agranulocytosis, thrombocytopenia, anaemia , leucocytosis, thrombocytosis, eosinophilia and altered platelet function.  (1). Clozapine is associated with several well-known abnormalities of blood cell count (2), but some case reports associate novel antipsychotics, such as risperidone  with leucopenia and agranulocytosis (3). This report describes a case of leucopenia under treatment with Oral Risperidone , suggesting the necessity of early recognition of leucopenia in order to prevent occurrence of potentially life-threatening agranulocytosis. ( 1) .


[M. Berghalout, A. Ait Idar, H. Guennouni, K.El Ouazzani, I. Adali and F. Manoudi (2021); RISPERIDONE INDUCED LEUCOPENIA AND NEUTROPENIA: A CASE REPORT AND BRIEF REVIEW OF LITERATURE Int. J. of Adv. Res. 9 (Feb). 724-726] (ISSN 2320-5407). www.journalijar.com


BERGHALOUT
PSYCHIATRY
Morocco

DOI:


Article DOI: 10.21474/IJAR01/12505      
DOI URL: https://dx.doi.org/10.21474/IJAR01/12505